Product
Azacitidine + Venetoclax
2 clinical trials
3 indications
Indication
Acute Myeloid LeukemiaIndication
hematologic malignanciesIndication
Stem Cell Transplant ComplicationsClinical trial
Azacitidine and Venetoclax (ABT-199) as Induction Therapy With Venetoclax Maintenance in Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML)Status: Active (not recruiting), Estimated PCD: 2024-12-15
Clinical trial
Azacitidine in Combination With Venetoclax Treatment for Prevention of Relapse in MRD Positive Post Allogeneic Hematopoietic Stem Cell Transplantation Acute Myelogenous Leukemia/ Myelodysplastic Syndrome PatientsStatus: Recruiting, Estimated PCD: 2024-03-19